BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan has surpassed itself again with the development of ultra-high-concentration lutein

According to the World Report on Vision published in 2020 by World Health Organization (WHO), the incidence of most eye diseases and visual impairments var...

July 14, 2021 | News

ADDI Announces Results of Inaugural Data Challenge

The challenge is a key part of our aim to end Alzheimer’s disease and related dementias by promoting open science and harnessing the power of collabo...

July 05, 2021 | News

Alterity Therapeutics granted a new US patent

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...

July 02, 2021 | News

Fighting Alzheimer’s disease with single cell research: Understanding selective neuronal vulnerability

Watching someone you love lose their precious memories, independence, and sense of self as Alzheimer’s disease (AD) claims their mind is heartbreakin...

June 22, 2021 | Opinion | By Leidamarie Tirado-Lee

Digital therapy services for neuropsychiatric illnesses are a priority in Korea.

KT Corporation and NeuroSigma, Inc. jointly announced signing of a memorandum of understanding, forming a strategic partnership to develop and commercializ...

June 15, 2021 | News

AAS : Next Steps For New Alzheimer's Treatment

Additionally, the FDA appropriately took into account the vast unmet need of the Alzheimer's community. Aduhelm is certainly not a cure, but at long last i...

June 14, 2021 | News

“700,000 people in USA are living with primary brain tumour”

Brain tumors originate from the brain itself, or it can be secondary extension from other parts. Brain tumors in India comes to 5-10 in 100,000 popul...

June 08, 2021 | Opinion

Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress

Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's an...

June 08, 2021 | Analysis

FDA Approval of Aducanumab

Neurimmune welcomes the news that the U.S. Food and Drug Administration (FDA) has approved Biogen's regulatory application for the use of aducanumab in the...

June 08, 2021 | News

Arctic Vision Announces the Treatment of Dry Eye Disease

iTEAR®100 is an FDA-cleared external neurostimulation device that increases acute tear production. Arctic Vision, a clinical stage biotech company foc...

June 07, 2021 | News

Cognoa Receives FDA Marketing Authorization for Autism Diagnosis Aid

– Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health...

June 03, 2021 | News

TLC and Strides partner to launch Black Fungus Drug in India

TLC (Nasdaq: TLC, TWO: 4152), a clinical‐stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, and...

June 02, 2021 | News

IPM Launches Mental Health Programme

Integrated Prescription Management (IPM), a leading pharmacy benefits management (PBM) company, now offers pharmacogenomics testing for patients...

May 29, 2021 | News

Most COVID-19 Patients Have Long-term Neurological Problems

In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...

May 25, 2021 | Analysis

Stay Connected